Reaction

Retinoblastoma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 108 reports · 7 co-occurring drugs

As of the last recalculation, Retinoblastoma appears in 108 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is MELPHALAN HYDROCHLORIDE (PRR 249.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Melphalan Hydrochloride25249.7250.0
Nevirapine10235.3235.6
Lamivudine25202.6202.8
Zidovudine12194.4194.6
Lamivudine Oral19175.4175.6
Ritonavir 100 Mg12174.0174.2
Atazanavir8115.8115.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.